Letifend

RSS

Authorised

This medicine is authorised for use in the European Union

canine leishmaniasis vaccine (recombinant protein)
MedicineVeterinaryAuthorised

Italian is available via eTranslation, the European Commission's machine translation service.

Translate to Italian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

български (BG) (93.36 KB - PDF)

Visualizza

español (ES) (81.97 KB - PDF)

Visualizza

čeština (CS) (93.99 KB - PDF)

Visualizza

dansk (DA) (83.34 KB - PDF)

Visualizza

Deutsch (DE) (82.76 KB - PDF)

Visualizza

eesti (ET) (82.18 KB - PDF)

Visualizza

ελληνικά (EL) (93.76 KB - PDF)

Visualizza

français (FR) (82.44 KB - PDF)

Visualizza

Gaeilge (GA) (83.57 KB - PDF)

Visualizza

hrvatski (HR) (92.27 KB - PDF)

Visualizza

italiano (IT) (82.29 KB - PDF)

Visualizza

latviešu (LV) (94.29 KB - PDF)

Visualizza

lietuvių (LT) (94.03 KB - PDF)

Visualizza

magyar (HU) (94.15 KB - PDF)

Visualizza

Malti (MT) (95.95 KB - PDF)

Visualizza

Nederlands (NL) (82.05 KB - PDF)

Visualizza

polski (PL) (95.62 KB - PDF)

Visualizza

português (PT) (83.01 KB - PDF)

Visualizza

română (RO) (94.17 KB - PDF)

Visualizza

slovenčina (SK) (94.08 KB - PDF)

Visualizza

slovenščina (SL) (82.27 KB - PDF)

Visualizza

suomi (FI) (81.54 KB - PDF)

Visualizza

svenska (SV) (82.05 KB - PDF)

Visualizza

Íslenska (IS) (83.29 KB - PDF)

Visualizza

norsk (NO) (82 KB - PDF)

Visualizza

Product information

български (BG) (91.78 KB - PDF)

Visualizza

español (ES) (81.51 KB - PDF)

Visualizza

čeština (CS) (92.48 KB - PDF)

Visualizza

dansk (DA) (82.05 KB - PDF)

Visualizza

Deutsch (DE) (81.72 KB - PDF)

Visualizza

eesti (ET) (81.22 KB - PDF)

Visualizza

ελληνικά (EL) (91.79 KB - PDF)

Visualizza

français (FR) (81.63 KB - PDF)

Visualizza

Gaeilge (GA) (81.36 KB - PDF)

Visualizza

hrvatski (HR) (91.56 KB - PDF)

Visualizza

italiano (IT) (81.76 KB - PDF)

Visualizza

latviešu (LV) (92.14 KB - PDF)

Visualizza

lietuvių (LT) (92.19 KB - PDF)

Visualizza

magyar (HU) (92.76 KB - PDF)

Visualizza

Malti (MT) (93.86 KB - PDF)

Visualizza

Nederlands (NL) (81.15 KB - PDF)

Visualizza

polski (PL) (93.22 KB - PDF)

Visualizza

português (PT) (82.53 KB - PDF)

Visualizza

română (RO) (91.73 KB - PDF)

Visualizza

slovenčina (SK) (81.75 KB - PDF)

Visualizza

slovenščina (SL) (81.76 KB - PDF)

Visualizza

suomi (FI) (81.11 KB - PDF)

Visualizza

svenska (SV) (81.47 KB - PDF)

Visualizza

Íslenska (IS) (81.52 KB - PDF)

Visualizza

norsk (NO) (81.52 KB - PDF)

Visualizza

български (BG) (93.36 KB - PDF)

Visualizza

español (ES) (81.97 KB - PDF)

Visualizza

čeština (CS) (93.99 KB - PDF)

Visualizza

dansk (DA) (83.34 KB - PDF)

Visualizza

Deutsch (DE) (82.76 KB - PDF)

Visualizza

eesti (ET) (82.18 KB - PDF)

Visualizza

ελληνικά (EL) (93.76 KB - PDF)

Visualizza

français (FR) (82.44 KB - PDF)

Visualizza

Gaeilge (GA) (83.57 KB - PDF)

Visualizza

hrvatski (HR) (92.27 KB - PDF)

Visualizza

italiano (IT) (82.29 KB - PDF)

Visualizza

latviešu (LV) (94.29 KB - PDF)

Visualizza

lietuvių (LT) (94.03 KB - PDF)

Visualizza

magyar (HU) (94.15 KB - PDF)

Visualizza

Malti (MT) (95.95 KB - PDF)

Visualizza

Nederlands (NL) (82.05 KB - PDF)

Visualizza

polski (PL) (95.62 KB - PDF)

Visualizza

português (PT) (83.01 KB - PDF)

Visualizza

română (RO) (94.17 KB - PDF)

Visualizza

slovenčina (SK) (94.08 KB - PDF)

Visualizza

slovenščina (SL) (82.27 KB - PDF)

Visualizza

suomi (FI) (81.54 KB - PDF)

Visualizza

svenska (SV) (82.05 KB - PDF)

Visualizza

Íslenska (IS) (83.29 KB - PDF)

Visualizza

norsk (NO) (82 KB - PDF)

Visualizza

Product details

Name of medicine
Letifend
Active substance
recombinant protein Q from Leishmania infantum MON-1
International non-proprietary name (INN) or common name
canine leishmaniasis vaccine (recombinant protein)

Pharmacotherapeutic group

Inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia)

Authorisation details

EMA product number
EMEA/V/C/003865

Assessment history

This page was last updated on

Share this page